Early clinical results with the Tendyne transcatheter mitral valve replacement system.

MedStar author(s):
Citation: Annals of Cardiothoracic Surgery. 7(6):776-779, 2018 Nov.PMID: 30598892Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2018ISSN:
  • 2225-319X
Name of journal: Annals of cardiothoracic surgeryAbstract: Transcatheter mitral valve replacement is an emerging technology for the treatment of mitral valve regurgitation. Numerous devices are in development and in various stages of clinical investigation. The Tendyne system (Tendyne Holdings, LLC, a subsidiary of Abbott Vascular, Roseville, Minnesota) is a fully repositionable and retrievable, transapical transcatheter mitral valve replacement platform. The results of the early feasibility studies in the U.S. are highly encouraging and a pivotal randomized trial is underway. The Tendyne transcatheter mitral valve replacement valve may prove to be a safe, less invasive approach to treatment of mitral valve disease.All authors: Ailawadi G, Beller JP, Rogers JH, Thourani VHFiscal year: FY2019Digital Object Identifier: Date added to catalog: 2019-01-18
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30598892 Available 30598892

Transcatheter mitral valve replacement is an emerging technology for the treatment of mitral valve regurgitation. Numerous devices are in development and in various stages of clinical investigation. The Tendyne system (Tendyne Holdings, LLC, a subsidiary of Abbott Vascular, Roseville, Minnesota) is a fully repositionable and retrievable, transapical transcatheter mitral valve replacement platform. The results of the early feasibility studies in the U.S. are highly encouraging and a pivotal randomized trial is underway. The Tendyne transcatheter mitral valve replacement valve may prove to be a safe, less invasive approach to treatment of mitral valve disease.

English

Powered by Koha